BRAINSWAY LTD-ADR (BWAY) Fundamental Analysis & Valuation

NASDAQ:BWAY • US10501L1061

12.45 USD
+0.86 (+7.42%)
At close: Mar 4, 2026
12.61 USD
+0.16 (+1.29%)
Pre-Market: 3/5/2026, 4:00:25 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This BWAY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

BWAY gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. While BWAY has a great health rating, its profitability is only average at the moment. BWAY is evaluated to be cheap and growing strongly. This does not happen too often! These ratings would make BWAY suitable for value and growth investing!


Dividend Valuation Growth Profitability Health

5

1. BWAY Profitability Analysis

1.1 Basic Checks

  • In the past year BWAY was profitable.
  • In the past year BWAY had a positive cash flow from operations.
  • BWAY had negative earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: BWAY reported negative operating cash flow in multiple years.
BWAY Yearly Net Income VS EBIT VS OCF VS FCFBWAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 5.53%, BWAY belongs to the top of the industry, outperforming 83.15% of the companies in the same industry.
  • The Return On Equity of BWAY (8.92%) is better than 83.70% of its industry peers.
  • BWAY's Return On Invested Capital of 2.75% is fine compared to the rest of the industry. BWAY outperforms 69.57% of its industry peers.
Industry RankSector Rank
ROA 5.53%
ROE 8.92%
ROIC 2.75%
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
BWAY Yearly ROA, ROE, ROICBWAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

  • BWAY has a Profit Margin of 12.73%. This is amongst the best in the industry. BWAY outperforms 87.50% of its industry peers.
  • The Operating Margin of BWAY (5.78%) is better than 70.65% of its industry peers.
  • BWAY's Gross Margin of 74.92% is amongst the best of the industry. BWAY outperforms 85.33% of its industry peers.
  • In the last couple of years the Gross Margin of BWAY has remained more or less at the same level.
Industry RankSector Rank
OM 5.78%
PM (TTM) 12.73%
GM 74.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
BWAY Yearly Profit, Operating, Gross MarginsBWAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. BWAY Health Analysis

2.1 Basic Checks

  • BWAY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • BWAY has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for BWAY has been increased compared to 5 years ago.
  • BWAY has a worse debt/assets ratio than last year.
BWAY Yearly Shares OutstandingBWAY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
BWAY Yearly Total Debt VS Total AssetsBWAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • An Altman-Z score of 3.44 indicates that BWAY is not in any danger for bankruptcy at the moment.
  • BWAY has a Altman-Z score of 3.44. This is in the better half of the industry: BWAY outperforms 70.65% of its industry peers.
  • BWAY has a debt to FCF ratio of 0.37. This is a very positive value and a sign of high solvency as it would only need 0.37 years to pay back of all of its debts.
  • BWAY has a Debt to FCF ratio of 0.37. This is amongst the best in the industry. BWAY outperforms 91.85% of its industry peers.
  • A Debt/Equity ratio of 0.08 indicates that BWAY is not too dependend on debt financing.
  • BWAY has a Debt to Equity ratio of 0.08. This is in the better half of the industry: BWAY outperforms 65.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.37
Altman-Z 3.44
ROIC/WACC0.32
WACC8.52%
BWAY Yearly LT Debt VS Equity VS FCFBWAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • BWAY has a Current Ratio of 3.19. This indicates that BWAY is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of BWAY (3.19) is comparable to the rest of the industry.
  • BWAY has a Quick Ratio of 3.02. This indicates that BWAY is financially healthy and has no problem in meeting its short term obligations.
  • BWAY's Quick ratio of 3.02 is fine compared to the rest of the industry. BWAY outperforms 65.76% of its industry peers.
Industry RankSector Rank
Current Ratio 3.19
Quick Ratio 3.02
BWAY Yearly Current Assets VS Current LiabilitesBWAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. BWAY Growth Analysis

3.1 Past

  • BWAY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 260.14%, which is quite impressive.
  • Looking at the last year, BWAY shows a very strong growth in Revenue. The Revenue has grown by 27.08%.
  • BWAY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.17% yearly.
EPS 1Y (TTM)260.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.08%
Revenue 1Y (TTM)27.08%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%16.38%

3.2 Future

  • The Earnings Per Share is expected to grow by 54.11% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, BWAY will show a quite strong growth in Revenue. The Revenue will grow by 18.80% on average per year.
EPS Next Y77.47%
EPS Next 2Y45.17%
EPS Next 3Y54.11%
EPS Next 5YN/A
Revenue Next Year9.31%
Revenue Next 2Y16.13%
Revenue Next 3Y18.8%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BWAY Yearly Revenue VS EstimatesBWAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
BWAY Yearly EPS VS EstimatesBWAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 -2

More info and screens

Find the best growth stocksShow best growing peers

8

4. BWAY Valuation Analysis

4.1 Price/Earnings Ratio

  • BWAY is valuated reasonably with a Price/Earnings ratio of 11.75.
  • 92.93% of the companies in the same industry are more expensive than BWAY, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 27.03. BWAY is valued rather cheaply when compared to this.
  • The Price/Forward Earnings ratio is 10.00, which indicates a very decent valuation of BWAY.
  • Based on the Price/Forward Earnings ratio, BWAY is valued cheaply inside the industry as 95.11% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of BWAY to the average of the S&P500 Index (25.11), we can say BWAY is valued rather cheaply.
Industry RankSector Rank
PE 11.75
Fwd PE 10
BWAY Price Earnings VS Forward Price EarningsBWAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • BWAY's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BWAY is cheaper than 66.30% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, BWAY is valued cheaply inside the industry as 96.74% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.31
EV/EBITDA 37.67
BWAY Per share dataBWAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • BWAY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BWAY's earnings are expected to grow with 54.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.15
PEG (5Y)N/A
EPS Next 2Y45.17%
EPS Next 3Y54.11%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BWAY Dividend Analysis

5.1 Amount

  • BWAY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BWAY Fundamentals: All Metrics, Ratios and Statistics

BRAINSWAY LTD-ADR

NASDAQ:BWAY (3/4/2026, 8:11:38 PM)

Premarket: 12.61 +0.16 (+1.29%)

12.45

+0.86 (+7.42%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-11
Earnings (Next)03-11
Inst Owners4.9%
Inst Owner Change10.06%
Ins Owners16.11%
Ins Owner ChangeN/A
Market Cap244.12M
Revenue(TTM)49.09M
Net Income(TTM)6.25M
Analysts85.71
Price TargetN/A
Short Float %N/A
Short Ratio0.49
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)65.34%
Min EPS beat(2)35.56%
Max EPS beat(2)95.12%
EPS beat(4)3
Avg EPS beat(4)50.32%
Min EPS beat(4)-22.64%
Max EPS beat(4)95.12%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.57%
Min Revenue beat(2)-1.07%
Max Revenue beat(2)-0.08%
Revenue beat(4)1
Avg Revenue beat(4)-0.87%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)0.01%
Revenue beat(8)4
Avg Revenue beat(8)-0.3%
Revenue beat(12)6
Avg Revenue beat(12)-11.32%
Revenue beat(16)6
Avg Revenue beat(16)-26.49%
PT rev (1m)2.01%
PT rev (3m)6.19%
EPS NQ rev (1m)-0.12%
EPS NQ rev (3m)-9.7%
EPS NY rev (1m)-0.12%
EPS NY rev (3m)7.64%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.81%
Revenue NY rev (1m)-3.87%
Revenue NY rev (3m)-4.95%
Valuation
Industry RankSector Rank
PE 11.75
Fwd PE 10
P/S 4.97
P/FCF 13.31
P/OCF 10.96
P/B 3.48
P/tB 3.48
EV/EBITDA 37.67
EPS(TTM)1.06
EY8.51%
EPS(NY)1.25
Fwd EY10%
FCF(TTM)0.94
FCFY7.51%
OCF(TTM)1.14
OCFY9.12%
SpS2.5
BVpS3.57
TBVpS3.57
PEG (NY)0.15
PEG (5Y)N/A
Graham Number9.23
Profitability
Industry RankSector Rank
ROA 5.53%
ROE 8.92%
ROCE 3.26%
ROIC 2.75%
ROICexc 15.43%
ROICexgc 15.43%
OM 5.78%
PM (TTM) 12.73%
GM 74.92%
FCFM 37.36%
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.37
Debt/EBITDA 1.21
Cap/Depr 207.6%
Cap/Sales 8.01%
Interest Coverage 26.28
Cash Conversion 470.69%
Profit Quality 293.55%
Current Ratio 3.19
Quick Ratio 3.02
Altman-Z 3.44
F-Score5
WACC8.52%
ROIC/WACC0.32
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)260.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.08%
EPS Next Y77.47%
EPS Next 2Y45.17%
EPS Next 3Y54.11%
EPS Next 5YN/A
Revenue 1Y (TTM)27.08%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%16.38%
Revenue Next Year9.31%
Revenue Next 2Y16.13%
Revenue Next 3Y18.8%
Revenue Next 5YN/A
EBIT growth 1Y147.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6.54%
EBIT Next 3Y43.13%
EBIT Next 5YN/A
FCF growth 1Y441.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y749.36%
OCF growth 3Y127.03%
OCF growth 5YN/A

BRAINSWAY LTD-ADR / BWAY FAQ

What is the fundamental rating for BWAY stock?

ChartMill assigns a fundamental rating of 6 / 10 to BWAY.


Can you provide the valuation status for BRAINSWAY LTD-ADR?

ChartMill assigns a valuation rating of 8 / 10 to BRAINSWAY LTD-ADR (BWAY). This can be considered as Undervalued.


How profitable is BRAINSWAY LTD-ADR (BWAY) stock?

BRAINSWAY LTD-ADR (BWAY) has a profitability rating of 5 / 10.


Can you provide the expected EPS growth for BWAY stock?

The Earnings per Share (EPS) of BRAINSWAY LTD-ADR (BWAY) is expected to grow by 77.47% in the next year.